This year, the Biology Department is also organizing the Annual PhD Conference in Biomedical Sciences, which will take place on the 8th-10th of November at the University Campus in Brno. More than 50 PhD students from various departments of the Faculty of Medicine, CEITEC MU and FNUSA-ICRC will present the results of their dissertations in the field of Biomedicine.
The Annual PhD Conference in Biomedical Sciences aims to bring together PhD students from different fields offering a chance to present their research in front of a miscellaneous audience promoting open discussions among participants.
The conference will be held among students of all three specializations following the idea "More people, more science & more fun!". Therefore, all students in the program take active part creating a team spirit, facilitating exchange of ideas and promoting communication between different departments.
The conference starts on the 8th November and the registration desk will be open from 07:45 - 08:15 (meeting room B06/201).
This year, the conference will last three days. Overall, 14 students will give talks as part of their doctoral state exams, 6 students will present their progress report s and 40 students will present posters during two poster sessions, which create great environment for networking. Please, see the program of the conference for more details.
The book of abstracts is available here.
We believe that the PhD conference will meet its goals and create an inspiring environment for all participants.
In September this year, the team of Prof. Slabý launched The BabyFox project. Its primary goal is to obtain the results of rapid whole-genome sequencing (rWGS) in patients with genetic diseases in neonatal and pediatric intensive care units in the shortest possible time, within seven days at the latest.
Scientists from the Biology department at the Faculty of Medicine, Masaryk University discovered new mechanisms controlling the division of tumor cells while studying skin melanomas. Their findings represent an important springboard for future drug development.
